ZELAPAR Side Effects

6830644-9 | Condition Aggravated, Dyskinesia, Parkinson's Disease
on Jul 09, 2010 Male patient from UNITED STATES , 43 years of age, weighting 135.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Zelapar (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, dyskinesia, parkinson's disease (What is parkinson's disease?). Zelapar dosage: 2.5 Mg 1x A Day Oral.

5815820-6 | Hypertensive Crisis
Patient was taking Zelapar (View Usage). Patient had the following side effects: hypertensive crisis on Mar 25, 2008 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Zelapar dosage: 1.25 Mg;qd;po. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), EXELON (View Exelon Review and Exelon Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), COLACE (View Colace Review and Colace Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

5815802-4 | Asthenia, Nausea, Weight Decreased
Adverse event was reported on Mar 24, 2008 by a Male patient taking Zelapar (View Usage) (Dosage: 1.25 Mg) . Location: UNITED STATES , 90 years of age, weighting 140.0 lb, After Zelapar was administered, patient had the following side effects: asthenia, nausea (What is nausea?), weight decreased. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SINEMET (View Sinemet Review and Sinemet Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), COREG (View Coreg Review and Coreg Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NITROSTAT (View Nitrostat Review and Nitrostat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MILK OF MAGNESIA (View Milk Of Magnesia Review and Milk Of Magnesia Label ). Patient was hospitalized.

5703583-4 | Balance Disorder, Diplopia, Dizziness, Fall, Gastric Ulcer Haemorrhage, Labyrinthitis, Presyncope, Spinal Compression Fracture, Urinary Retention
on Mar 31, 2008 Male patient from UNITED STATES , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Zelapar (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, diplopia, dizziness (What is dizziness?), fall (What is fall?), gastric ulcer haemorrhage, labyrinthitis, presyncope, spinal compression fracture, urinary retention. Zelapar dosage: 1.25 Mg;qd;po, 2.5 Mg;qd;po. During the same period patient was treated with COGENTIN (View Cogentin Review and Cogentin Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SINEMET (View Sinemet Review and Sinemet Label ), PROVIGIL (View Provigil Review and Provigil Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ). Patient was hospitalized.


5627074-4 | Condition Aggravated, Dehydration, Dizziness, Fatigue, Insomnia, Orthostatic Hypotension, Tremor, Urinary Tract Infection
on Oct 01, 2007 Female patient from UNITED STATES , 81 years of age, weighting 139.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Zelapar (View Usage). Patient had the following side effects: condition aggravated, dehydration, dizziness (What is dizziness?), fatigue, insomnia, orthostatic hypotension, tremor, urinary tract infection (What is urinary tract infection?). Zelapar dosage: 1.25 Mg;qd;po. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (0.25 Mg;tid;po ; 0.25 Mg;tid;po ;0.125 Mg;tid;po) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), STAVELO (View Stavelo Review and Stavelo Label ), VERAPAMIL SLOW RELEASE (View Verapamil - Slow Release Review and Verapamil - Slow Release Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), PEPCID AC (View Pepcid Ac Review and Pepcid Ac Label ). Patient was hospitalized.

5567895-X | Dysarthria, Fall, Haemoptysis, Headache, Pulmonary Embolism, Syncope, Thrombosis
Patient was taking Zelapar (View Usage). After Zelapar was administered, patient had the following side effects: dysarthria, fall (What is fall?), haemoptysis, headache (What is headache?), pulmonary embolism (What is pulmonary embolism?), syncope, thrombosis on Dec 05, 2007 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 162.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Zelapar dosage: 1.25 Mg;qd;po. During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PRAMIPREXOLE (View Pramiprexole Review and Pramiprexole Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5199590-3 | Anaemia, Mental Status Changes, Oesophagitis
Adverse event was reported on Jan 03, 2007 by a Female patient taking Zelapar (View Usage) (Dosage: 1.25mg Daily Oral) was diagnosed with parkinson's disease (What is parkinson's disease?), depression (What is depression?) and. Location: UNITED STATES , 83 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, mental status changes, oesophagitis. During the same period patient was treated with LEXAPRO (10mg Daily Oral) (View Lexapro Review and Lexapro Label ). Patient was hospitalized.